Tech Company Financing Transactions

eGenesis Funding Round

eGenesis closed a $125 million Series C funding round on 3/3/2021. Investors included Alta Partners, Altium Capital and Arch Venture Partners.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
The company intends to use the funds to bring its lead programs in kidney and islet cell transplant into human proof-of-concept studies and continue to develop its proprietary gene-editing platform and scaling of GMP production.

Company Information

Company Status
Private & Independent
Mailing Address
300 Technology Sq. 301
Cambridge, MA 02139
Email Address
eGenesis is a life sciences company focused on leveraging CRISPR technology to deliver safe and effective human transplantable cells, tissues and organs to the hundreds of thousands of patients worldwide who are in dire need.
eGenesis LinkedIn Company Profile
Social Media
eGenesis Company Twitter Account
Company News
eGenesis News
eGenesis on Facebook
eGenesis on YouTube

Management Team

Email & Social
Chief Executive Officer
Paul Sekhri
  Paul Sekhri LinkedIn Profile  Paul Sekhri Twitter Account  Paul Sekhri News  Paul Sekhri on Facebook
Chief Operating Officer
Peter Hanson
  Peter Hanson LinkedIn Profile  Peter Hanson Twitter Account  Peter Hanson News  Peter Hanson on Facebook
VP - Bus. Development
Jennifer Bergheiser
  Jennifer Bergheiser LinkedIn Profile  Jennifer Bergheiser Twitter Account  Jennifer Bergheiser News  Jennifer Bergheiser on Facebook
VP - Bus. Development
Ariel Jasie
  Ariel Jasie LinkedIn Profile  Ariel Jasie Twitter Account  Ariel Jasie News  Ariel Jasie on Facebook
VP - Human Resources
Elizabeth Roberts
  Elizabeth Roberts LinkedIn Profile  Elizabeth Roberts Twitter Account  Elizabeth Roberts News  Elizabeth Roberts on Facebook
VP - R & D
Michael Curtis
  Michael Curtis LinkedIn Profile  Michael Curtis Twitter Account  Michael Curtis News  Michael Curtis on Facebook
VP - Regulatory Affairs
David Carmel
  David Carmel LinkedIn Profile  David Carmel Twitter Account  David Carmel News  David Carmel on Facebook



Browse more venture capital transactions:

Prev: 3/3/2021: Presage Biosciences venture capital transaction
Next: 3/3/2021: Reperio Health venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary